<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05627830</url>
  </required_header>
  <id_info>
    <org_study_id>111996</org_study_id>
    <nct_id>NCT05627830</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Versus Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint.</brief_title>
  <official_title>Ultrasound Guided Versus Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ultrasound Guided Versus Non-Guided Prolotherapy for Treatment of Internal Derangement of&#xD;
      Temporomandibular joint.&#xD;
&#xD;
      Rationale for conducting the research:&#xD;
&#xD;
      The most critical cause for guided prolotherapy is to specify the accurate location of&#xD;
      glenoid fossa and the disc space while prolotherapy procedure, and to adjust the needle&#xD;
      insertion to according to articular eminence, mandibular condyle, and intra-articular space&#xD;
      as anatomical variations. The vibration of ultrasound waves generates a heat so there is a&#xD;
      thermal effective for prolotherapy effusion in the TMJ space.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 10, 2022</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue scale</measure>
    <time_frame>Change from Baseline VAS at 4 weeks ( lower score means better outcome)</time_frame>
    <description>psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analogue scale</measure>
    <time_frame>VAS change at 2 months ( lower score means better outcome )</time_frame>
    <description>psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>TMJ Disc Disorder</condition>
  <condition>Ultrasound Therapy; Complications</condition>
  <condition>TMJ</condition>
  <condition>Prolotherapy</condition>
  <condition>Internal Derangement</condition>
  <condition>Clicking Tinnitus</condition>
  <condition>Injection Site</condition>
  <condition>Pain, Chronic</condition>
  <condition>Anterior Disc Displacement</condition>
  <condition>Myofascial Pain Syndrome</condition>
  <condition>Masticatory Muscle</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guided Prolotherapy forTreatment of Internal Derangement of TMJD.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection procedure in TMJ Space guided by ultrasound probe the injection materials will be composition of ( !0% Dextrose ) + (Saline ) + (2% Lidocaine, plain anesthesia ).&#xD;
The intervention procedure will done after TMJ MRI assessment for patients who have anterior disc displacement with reduction (DDWR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Guided Ultrasound ( Blind) Prolotherapy for Treatment of Internal Derangement of TMJD.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection procedure in TMJ Space by anatomical land mark (blindly), and we also call it ( conventional prolotherapy ) the injection materials will be composition of ( !0% Dextrose ) + (Saline ) + (2% Lidocaine, plain anesthesia ).&#xD;
The intervention procedure will done after TMJ MRI assessment for patients who have anterior disc displacement with reduction (DDWR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prolotherapy</intervention_name>
    <description>Prolotherapy is an injection treatment used to relieve pain. And for Cellular Regeneration</description>
    <arm_group_label>Non-Guided Ultrasound ( Blind) Prolotherapy for Treatment of Internal Derangement of TMJD.</arm_group_label>
    <arm_group_label>Ultrasound Guided Prolotherapy forTreatment of Internal Derangement of TMJD.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with TMD - internal derangement with symptomatic clicking pain, according to&#xD;
             RDC (Research diagnostic criteria for TMJD) sheet .&#xD;
&#xD;
          2. Muscles spasm causing TMDs.&#xD;
&#xD;
          3. Patients who failed to improve on conservative measures or highly hyperactivity&#xD;
             patients.&#xD;
&#xD;
          4. Female and male patients age range from 20 to 60 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who refused to be included in the research.&#xD;
&#xD;
          2. Patients with a systemically diseases or inflammation whether local or generalized.&#xD;
&#xD;
          3. Patients with bleeding disorders.&#xD;
&#xD;
          4. Patients with unknown dextrose allergy.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tarek Abdallah EL-Ghareeb, M.D.</last_name>
    <phone>00201227418235</phone>
    <email>t.elghareeb@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>CairoU</name>
      <address>
        <city>Cairo</city>
        <state>Al Manial, Old Cairo</state>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omniya Abdelaziz, M.D.</last_name>
      <phone>00201001202583</phone>
      <email>omniya.abdelaziz@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 15, 2022</study_first_submitted>
  <study_first_submitted_qc>November 22, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2022</study_first_posted>
  <last_update_submitted>February 6, 2023</last_update_submitted>
  <last_update_submitted_qc>February 6, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohammad Bader AL-Haj Kheder</investigator_full_name>
    <investigator_title>Oral &amp; Maxillofacial Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Tinnitus</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data of volunteers will be shared with the doctors supervising the thesis research to assess the status and results of the scientific research</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

